BG100245A - N-substituted azaheterocyclic carboxylic acids and their esters - Google Patents
N-substituted azaheterocyclic carboxylic acids and their estersInfo
- Publication number
- BG100245A BG100245A BG100245A BG10024595A BG100245A BG 100245 A BG100245 A BG 100245A BG 100245 A BG100245 A BG 100245A BG 10024595 A BG10024595 A BG 10024595A BG 100245 A BG100245 A BG 100245A
- Authority
- BG
- Bulgaria
- Prior art keywords
- phenyl
- membered
- substituted
- esters
- carboxylic acids
- Prior art date
Links
- 150000001735 carboxylic acids Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000003304 gavage Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK93744A DK74493D0 (da) | 1993-06-23 | 1993-06-23 | Novel heterocyclic chemistry |
| PCT/DK1994/000251 WO1995000484A1 (en) | 1993-06-23 | 1994-06-22 | N-substituted azaheterocyclic carboxylic acids and esters thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG100245A true BG100245A (en) | 1996-05-31 |
Family
ID=8097043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100245A BG100245A (en) | 1993-06-23 | 1995-12-21 | N-substituted azaheterocyclic carboxylic acids and their esters |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5639766A (hu) |
| EP (1) | EP0707568A1 (hu) |
| JP (1) | JPH08511781A (hu) |
| CN (1) | CN1128991A (hu) |
| AU (1) | AU6996094A (hu) |
| BG (1) | BG100245A (hu) |
| CA (1) | CA2165948A1 (hu) |
| CZ (1) | CZ335595A3 (hu) |
| DK (1) | DK74493D0 (hu) |
| FI (1) | FI956175A (hu) |
| HU (1) | HUT73242A (hu) |
| IL (1) | IL110076A0 (hu) |
| NO (1) | NO955261L (hu) |
| SK (1) | SK162395A3 (hu) |
| WO (1) | WO1995000484A1 (hu) |
| ZA (1) | ZA944468B (hu) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK270488D0 (da) * | 1988-05-18 | 1988-05-18 | Novo Industri As | Hidtil ukendte o-substituerede ketoximer |
| DK93791D0 (da) * | 1991-05-17 | 1991-05-17 | Novo Nordisk As | Nye heterocykliske carboxylsyrer |
-
1993
- 1993-06-23 DK DK93744A patent/DK74493D0/da not_active Application Discontinuation
-
1994
- 1994-06-21 IL IL11007694A patent/IL110076A0/xx unknown
- 1994-06-22 CA CA002165948A patent/CA2165948A1/en not_active Abandoned
- 1994-06-22 WO PCT/DK1994/000251 patent/WO1995000484A1/en not_active Application Discontinuation
- 1994-06-22 ZA ZA944468A patent/ZA944468B/xx unknown
- 1994-06-22 JP JP7502351A patent/JPH08511781A/ja active Pending
- 1994-06-22 EP EP94918774A patent/EP0707568A1/en not_active Withdrawn
- 1994-06-22 AU AU69960/94A patent/AU6996094A/en not_active Abandoned
- 1994-06-22 CN CN94193060A patent/CN1128991A/zh active Pending
- 1994-06-22 CZ CZ953355A patent/CZ335595A3/cs unknown
- 1994-06-22 SK SK1623-95A patent/SK162395A3/sk unknown
- 1994-06-22 US US08/263,863 patent/US5639766A/en not_active Expired - Fee Related
- 1994-06-22 HU HU9503754A patent/HUT73242A/hu unknown
-
1995
- 1995-12-21 BG BG100245A patent/BG100245A/xx unknown
- 1995-12-21 FI FI956175A patent/FI956175A/fi unknown
- 1995-12-22 NO NO955261A patent/NO955261L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9503754D0 (en) | 1996-02-28 |
| IL110076A0 (en) | 1994-10-07 |
| NO955261D0 (no) | 1995-12-22 |
| JPH08511781A (ja) | 1996-12-10 |
| ZA944468B (en) | 1995-12-22 |
| US5639766A (en) | 1997-06-17 |
| NO955261L (no) | 1996-02-22 |
| CZ335595A3 (en) | 1996-07-17 |
| DK74493D0 (da) | 1993-06-23 |
| EP0707568A1 (en) | 1996-04-24 |
| AU6996094A (en) | 1995-01-17 |
| HUT73242A (en) | 1996-07-29 |
| FI956175A (fi) | 1996-02-21 |
| SK162395A3 (en) | 1996-09-04 |
| FI956175A0 (fi) | 1995-12-21 |
| CA2165948A1 (en) | 1995-01-05 |
| CN1128991A (zh) | 1996-08-14 |
| WO1995000484A1 (en) | 1995-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26733A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| NO306677B1 (no) | Heterosykliske forbindelser, farmasöytiske preparater og anvendelse av en slik forbindelse til fremstilling av et medikament | |
| NO854833L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykloforbindelser. | |
| DE69334250D1 (de) | Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern | |
| TR199800849T2 (xx) | Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri | |
| BR9401484A (pt) | Hidrazida de ácido 1h-indol-3-acético e formulação farmacêutica | |
| FI954130A0 (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
| PT863136E (pt) | Derivados de azetidina e de pirrolidina | |
| DE69329887T2 (de) | Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems | |
| NO890259L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| NO302523B1 (no) | Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter | |
| RU95105435A (ru) | N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства | |
| DE3763863D1 (de) | Substituierte tetrahydro-3-pyridincarbonsaeuren, ihre ester und amide als cholinergische mittel. | |
| NO864443L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater. | |
| FI903571A0 (fi) | Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi | |
| RU94046270A (ru) | Лактамовые дипептиды, обладающие ингибирующей активностью по отношению к эластазе лейкоцитов человека, способ получения, фармацевтическая композиция | |
| DD283381A5 (de) | Verfahren zur herstellung einer verbindung | |
| BG100245A (en) | N-substituted azaheterocyclic carboxylic acids and their esters | |
| EP0280224A3 (en) | Substituted 3h-indoles, process for their preparation and medicines containing them | |
| NO180269C (no) | Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater | |
| BG100246A (en) | N-substituted azaheterocylic carboxylic acids and their esters | |
| ATE40821T1 (de) | Gesaettigte zykloalkyl-c-pyrrole-2(1h)essigs|ureamide und deren derivate. | |
| FI103885B1 (fi) | Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä | |
| BG100249A (en) | N-substituted azaheterocyclic carboxylic acids and their esters | |
| FR2384791A1 (fr) | Nouveaux derives d'everninomicine, leur procede de preparation et compositions pharmaceutiques contenant lesdits derives |